Aram Boada
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- Dermatology top 5%
- Dermatological and COVID-19 studies
Papers in
- Oncology 49
- Cutaneous Melanoma Detection and Management 40
- Cancer Immunotherapy and Biomarkers 7
- Dermatology 10
- Chemotherapy-related skin toxicity 4
- Co-authors
- Carlos Ferrándiz (17 shared papers)J.M. Carrascosa (14 shared papers)María Teresa Fernández‐Figueras (7 shared papers)Isabel Bielsa (3 shared papers)Antonio Tejera Vaquerizo (8 shared papers)Cristina Carrera (9 shared papers)Teresa Morán (2 shared papers)Enric Carcereny (2 shared papers)
In The Last Decade
Aram Boada
84 papers receiving 891 citations
Peers
Comparison fields: 5 of 74
- Oncology 427
- Dermatology 97
- Epidemiology 111
- Immunology 62
- Urology 21
Countries citing papers authored by Aram Boada
This map shows the geographic impact of Aram Boada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aram Boada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aram Boada more than expected).
Fields of papers citing papers by Aram Boada
This network shows the impact of papers produced by Aram Boada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aram Boada. The network helps show where Aram Boada may publish in the future.
Co-authors
The 25 scholars most cited alongside Aram Boada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 69 | |
| 2 | 2010 | 58 | |
| 3 | 2018 | 55 | |
| 4 | 2019 | 44 | |
| 5 | 2019 | 34 | |
| 6 | 2011 | 32 | |
| 7 | 2015 | 32 | |
| 8 | 2021 | 32 | |
| 9 | 2009 | 30 | |
| 10 | 2018 | 29 | |
| 11 | 2019 | 28 | |
| 12 | 2017 | 27 | |
| 13 | 2018 | 25 | |
| 14 | 2019 | 23 | |
| 15 | 2020 | 22 | |
| 16 | 2019 | 19 | |
| 17 | 2019 | 18 | |
| 18 | 2017 | 16 | |
| 19 | 2016 | 15 | |
| 20 | 2021 | 15 |
About Aram Boada
Aram Boada is a scholar working on Oncology, Dermatology, Epidemiology, Health and Periodontics, having authored 96 papers that have together received 921 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (40 papers), Cancer Immunotherapy and Biomarkers (7 papers), Nonmelanoma Skin Cancer Studies (7 papers), Melanoma and MAPK Pathways (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Nail Diseases and Treatments (4 papers) and Chemotherapy-related skin toxicity (4 papers). The work is most often cited by research in Oncology (427 citations), Dermatology (97 citations), Epidemiology (111 citations), Immunology (62 citations) and Urology (21 citations). Aram Boada has collaborated with scholars based in Spain, Italy and China. Frequent co-authors include Carlos Ferrándiz, J.M. Carrascosa, María Teresa Fernández‐Figueras, Isabel Bielsa, Antonio Tejera Vaquerizo, Cristina Carrera, Teresa Morán, Enric Carcereny, Susana Puig and Josep Malvehy. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, Actas Dermo-Sifiliográficas, JAMA Dermatology, Journal of Clinical Medicine and American Journal of Dermatopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.